NGI

Clinical Research Services

National Genetics Institute (NGI) provides advanced genetics testing services for biopharmaceutical development and clinical research. We support numerous pharmaceutical and biotechnology companies in the clinical development of new infectious disease and oncology therapies and the NGI testing platform is used in multiple human clinical trials.

Our Clinical Research Services include:

 Assays Available for Research Use
 Infectious Agents  Oncology Markers
  • Human T-Cell Lymphotropic Virus (HTLV I/II)
  • Epstein-Barr Virus (EBV)
  • Cytomegalovirus (CMV)
  • Simian Virus 40 (SV40)
  • Hepatitis D Virus (HDV)
  • Hepatitis G Virus (HGV)
  • Tyrosinase
  • MART-1/Melan A
  • MAGE-3
  • gp100
  • Thymidylate Synthase

Contact NGI to find out how we can develop customized solutions for your research needs.

Test Menu

NGI offers a range of advanced genetics assays. Select a specific test below to obtain additional test information.

download PDF